COVID-19 Dangerous Vaccine Studies
Peer-reviewed research points to vaccine dangers
🎥
The following video was shared on social media on January 11, 2024. Sources – and direct links to view/share on multiple platforms – are provided at the bottom of this post. Please report broken links here.
Big Pharma COVID Profits
Pfizer sold $37.8 billion of its COVID vaccine in 2022 alone.
COVID Vaccine Studies
A study co-authored by the FDA looking at more than 25 million elderly people identified an association between the COVID vaccine and pulmonary embolism, heart attacks, and disorders that cause blood clotting, bruising, and bleeding.
Another review noted that new onset of autoimmune manifestations including liver diseases, Guillain–Barré syndrome, and blood clotting "appears to be associated" with the COVID vaccine.
See The Epoch Times for an incredible index of COVID vaccine heart studies.
A study of nearly 5 million people found the COVID vaccine was “associated with a significantly increased risk of myocarditis in the Danish population, primarily driven by an increased risk among individuals aged 12-39 years.”
A recent study found a decreased immune response to bacteria, fungi, and other viruses after children got the COVID vaccine.
Another study showed an increased risk of developing cavities.
A review of 271 cases across 39 countries found the COVID-19 vaccine “may trigger rheumatic immune-mediated inflammatory diseases.”
In a study of nearly 22,000 women at different stages of menopause, researchers identified a two to five-fold increase in unexpected bleeding.
An extensive literature review concluded that “with each booster comes a compounded risk of future neurodegenerative disease.”
Researchers warn that the possibility that the COVID vaccine might lead to cancer progression and recurrence “cannot be excluded at present.”
✏️ References
Alenazi, H. M. K., Baseer, M. A., AlMugeiren, O. M., & Ingle, N. A. (2023). Comparison of salivary secretion, pH, and buffer capacity between COVID-19 vaccinated and unvaccinated child patients visiting dental clinics of university hospitals in Riyadh City, Saudi Arabia. International Journal of General Medicine, 16: 6115–25.
Angues, R.V. & Bustos, Y.P. (17 December 2023). SARS-CoV-2 vaccination and the multi-hit hypothesis of oncogenesis. Cureus, 15(12): e50703.
Blix, K., Laake, I., Juvet, L., Robertson, A. H., Caspersen, I. H., Mjaaland, S., Skodvin, S. N., Magnus, P., Feiring, B., & Trogstad, L. (2023). Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women. Science Advances, 9(38): eadg1391.
Chen, Y., Xu, Z., Wang, P., Li, X. M., Shuai, Z. W., Ye, D. Q., & Pan, H. F. (2022). New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology, 165(4): 386-401.
Husby, A., Hansen, J. V., Fosbøl, E., Thiesson, E. M., Madsen, M., Thomsen, R. W., Sørensen, H. T., Andersen, M., Wohlfahrt, J., Gislason, G., Torp-Pedersen, C., Køber, L., & Hviid, A. (2021). SARS-CoV-2 vaccination and myocarditis or myopericarditis: Population based cohort study. British Medical Journal (Clinical Research Ed.), 375: e068665.
Kimball, S. (31 January 2023). The COVID Pandemic Drives Pfizer’s 2022 Revenue to a Record $100 Billion. CNBC.
Noé, A., Dang, T. D., Axelrad, C., Burrell, E., Germano, S., Elia, S., Burgner, D., Perrett, K. P., Curtis, N., & Messina, N. L. (2023). BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists. Frontiers in Immunology, 14: 1242380.
Nune, A., Durkowski, V., Pillay, S. S., Barman, B., Elwell, H., Bora, K., Bilgrami, S., Mahmood, S., Babajan, N., Venkatachalam, S., Ottewell, L., & Manzo, C. (2023). New-onset rheumatic immune-mediated inflammatory diseases following SARS-CoV-2 vaccinations until May 2023: A Systematic review. Vaccines, 11(10): 1571.
Seneff, S., Kyriakopoulos, A. M., Nigh, G., & McCullough, P. A. (2023). A potential role of the spike protein in neurodegenerative diseases: A narrative review. Cureus, 15(2): e34872.
Stieber, Z. (17 September 2023). Resource: Studies on Myocarditis and COVID-19 Vaccination. The Epoch Times.
Wong, H. L., Tworkoski, E., Ke Zhou, C., Hu, M., Thompson, D., Lufkin, B., Do, R., Feinberg, L., Chillarige, Y., Dimova, R., Lloyd, P. C., MaCurdy, T., Forshee, R. A., Kelman, J. A., Shoaibi, A., & Anderson, S. A. (2023). Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older. Vaccine, 41(2): 532-39.
Members Discussion
Join the discussion
Become a Serious Thinker to start commenting.
Get Access